Highlights
1 patent
About
Gene Therapy for Genetic and Infectious Diseases
LogicBio Therapeutics develops gene therapy vectors for previously incurable genetic and infectious diseases, including hemophilia, HIV/AIDS, and methylmalonic acidemia. The company's proprietary technology is based on the nonpathogenic adeno-associated viral vector. The technology may offer improved efficiency and safety, and it is well suited for the treatment of both children and adults.
Identity
| Name | LogicBio Therapeutics |
|---|---|
| Slug | logicbio-therapeutics |
| Type / kind | startup |
| Crunchbase ID | logicbio-therapeutics |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwPiB7YoJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Feb 2019 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Ness Ziona, Israel |
Web & social
| https://www.linkedin.com/company/11005499 | |
| Twitter / X | https://twitter.com/logicbio |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
genome-editingdrug-discoverypharmaceuticalsrare-diseasesdrug-discoverydrug-discoveryrare-diseasescell-therapygenetic-disorders
Funding
| Total raised | $119.0M |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}